ZyVersa Therapeutics, Inc. ZVSA shares are trading higher Monday after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for inhibiting ASC with IC 100 to potentially attenuate cardiac comorbidities in patients with Alzheimer’s Disease.
Open FlipSINTX Technologies Inc SINT shares are trading higher by 32% to $0.05 during Monday’s session after the company and Prodways Printers announced they have entered into a technical partnership and ceramic slurry supply agreement. Under this collaboration, SINTX and its subsidiary will provide ceramic-filled printable slurries to Prodways and aid in process development and customer support
Open FlipMonday, Addex Therapeutics ADXN released top-line data from a Phase 2 epilepsy study evaluating adjunctive ADX71149 (JNJ-40411813) administration in patients with focal onset seizures with suboptimal response to levetiracetam or brivaracetam. The company is collaborating with Johnson & Johnson’s JNJ Janssen Pharmaceuticals Inc.
Open Flip